O. I. Vernaya

554 citations

28 papers · 356 indexed · h-index 11

Co-authors: Т. И. Шабатина Mikhail Ya. Melnikov В. П. Шабатин А. М. Семенов Vladimir I. Lozinsky Andrew N. Fitch M.G. Ezernitskaya Владимир В. Чернышев
Topics: Nanoparticle-Based Drug Delivery (12 papers)Laser-Ablation Synthesis of Nanoparticles (7 papers)Nanoparticles: synthesis and applications (6 papers)
Cited by: Biomaterials Molecular Medicine Pharmaceutical Science
Journals: Molecules International Journal of Biological Macromolecules Materials
Partner nations: Russia Tajikistan France

In The Last Decade

O. I. Vernaya

27 papers receiving 349 citations

Peers

Countries citing papers authored by O. I. Vernaya

Since Specialization

Citations

This map shows the geographic impact of O. I. Vernaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. I. Vernaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. I. Vernaya more than expected).

Fields of papers citing papers by O. I. Vernaya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. I. Vernaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. I. Vernaya. The network helps show where O. I. Vernaya may publish in the future.

Co-authorship network of co-authors of O. I. Vernaya

This figure shows the co-authorship network connecting the top 25 collaborators of O. I. Vernaya. A scholar is included among the top collaborators of O. I. Vernaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. I. Vernaya. O. I. Vernaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmaceutical Nanoparticles Formation and Their Physico-Chemical and Biomedical Properties 2024 ·Pharmaceuticals ·Т. И. Шабатина,(unknown),O. I. Vernaya,(unknown),(unknown),(unknown),(unknown),Mikhail Ya. Melnikov	5
2	SYNTHESIS OF IRON OXIDES NANOPARTICLES BY THERMAL DECOMPOSITION OF CRYOCHEMICALLY MODIFIED IRON(III) ACETYLACETONATE 2023 ·O. I. Vernaya,(unknown),(unknown),Т. И. Шабатина,(unknown)	0
3	Metal and Metal Oxides Nanoparticles and Nanosystems in Anticancer and Antiviral Theragnostic Agents 2023 ·Pharmaceutics ·Т. И. Шабатина,O. I. Vernaya,(unknown),Mikhail Ya. Melnikov	35
4	Hybrid Nanosystems of Antibiotics with Metal Nanoparticles—Novel Antibacterial Agents 2023 ·Molecules ·Т. И. Шабатина,O. I. Vernaya,Mikhail Ya. Melnikov	31
5	Synthesis of Iron Oxide Nanoparticles by Thermal Decomposition of Cryochemically Modified Precursors 2022 ·Moscow University Chemistry Bulletin ·O. I. Vernaya,(unknown),(unknown),Т. И. Шабатина,Mikhail Ya. Melnikov	2
6	Nanoparticles of Bioactive Metals/Metal Oxides and Their Nanocomposites with Antibacterial Drugs for Biomedical Applications 2022 ·Materials ·Т. И. Шабатина,O. I. Vernaya,(unknown),(unknown),Mikhail Ya. Melnikov	39
7	Cryochemical Production of Drug Nanoforms: Particle Size and Crystal Phase Control of the Antibacterial Medication 2,3-Quinoxalinedimethanol-1,4-dioxide (Dioxidine) 2021 ·Nanomaterials ·Т. И. Шабатина,(unknown),(unknown),(unknown),O. I. Vernaya,Mikhail Ya. Melnikov	4
8	Influence of succinylation of a wide-pore albumin cryogels on their properties, structure, biodegradability, and release dynamics of dioxidine loaded in such spongy carriers 2020 ·International Journal of Biological Macromolecules ·Vladimir I. Lozinsky,(unknown),(unknown),O. I. Vernaya,(unknown),(unknown),M.G. Ezernitskaya,А. М. Семенов,Т. И. Шабатина,Mikhail Ya. Melnikov	15
9	Magnetic Nanoparticles for Biomedical Purposes: Modern Trends and Prospects 2020 ·Magnetochemistry ·Т. И. Шабатина,O. I. Vernaya,В. П. Шабатин,Mikhail Ya. Melnikov	105
10	Low-Temperature Synthesis and Antibacterial Activity of Hybrid Systems of Gentamicin Sulfate with Copper and Iron Nanoparticles 2020 ·Moscow University Chemistry Bulletin ·O. I. Vernaya,В. П. Шабатин,А. М. Семенов,Т. И. Шабатина,Mikhail Ya. Melnikov	5
11	Synthesis and Biological Activity of Hybrid Systems of Magnetic Nanoparticles with Antibacterial Drugs 2019 ·Moscow University Chemistry Bulletin ·O. I. Vernaya,(unknown),В. П. Шабатин,Т. И. Шабатина,Mikhail Ya. Melnikov	2
12	Metal Nanoparticle Containing Nanocomposites of Drug Substances and Their Potential Biomedical Applications 2019 ·Applied Sciences ·Т. И. Шабатина,O. I. Vernaya,В. П. Шабатин,Mikhail Ya. Melnikov,(unknown),Vladimir I. Lozinsky	3
13	Cryochemically Obtained Nanoforms of Antimicrobial Drug Substance Dioxidine and Their Physico-chemical and Structural Properties 2018 ·Crystals ·Т. И. Шабатина,O. I. Vernaya,В. П. Шабатин,(unknown),Mikhail Ya. Melnikov,Andrew N. Fitch,Владимир В. Чернышев	12
14	Hybrid Systems of Delivery of Long-Acting Drugs Based on Gentamicin Sulfate, Silver, and Copper Nanoparticles, and Gelatin Biopolymer Matrices 2018 ·Nanotechnologies in Russia ·Т. И. Шабатина,O. I. Vernaya,(unknown),(unknown),В. П. Шабатин,А. М. Семенов,(unknown),Mikhail Ya. Melnikov	10
15	Cryochemical synthesis and antibacterial activity of a hybrid composition based on Ag nanoparticles and dioxidine 2017 ·Moscow University Chemistry Bulletin ·O. I. Vernaya,В. П. Шабатин,А. М. Семенов,Т. И. Шабатина	10
16	Cu/dioxidine hybrid nanocomposites: cryochemical synthesis and antibacterial activity 2017 ·Moscow University Chemistry Bulletin ·O. I. Vernaya,(unknown),(unknown),(unknown),В. П. Шабатин,А. М. Семенов,Т. И. Шабатина	5
17	Effect of the support nature on the catalytic properties of iron in benzene benzylation 2017 ·Petroleum Chemistry ·O. I. Vernaya,(unknown),Yu. V. Maksimov,Т. Н. Ростовщикова	3
18	Cryochemical modification, activity, and toxicity of dioxidine 2017 ·Russian Journal of Physical Chemistry A ·O. I. Vernaya,В. П. Шабатин,Т. И. Шабатина,(unknown),А. М. Семенов,(unknown),(unknown)	12
19	Cryochemical modification of drugs: Nanosized form III piroxicam and its physical and chemical properties 2016 ·Moscow University Chemistry Bulletin ·(unknown),(unknown),В. П. Шабатин,O. I. Vernaya,(unknown),Anton S. Abel,(unknown),Т. И. Шабатина,Г.Б. Сергеев	4
20	Obtaining ultradispersed dioxidine powder modified via cryochemical synthesis and determining its antibacterial activity 2016 ·Moscow University Chemistry Bulletin ·O. I. Vernaya,В. П. Шабатин,А. М. Семенов,Т. И. Шабатина	10

About O. I. Vernaya

O. I. Vernaya is a scholar working on Biomaterials, Pharmaceutical Science and Molecular Medicine, having authored 28 papers that have together received 356 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (12 papers), Laser-Ablation Synthesis of Nanoparticles (7 papers) and Nanoparticles: synthesis and applications (6 papers). The work is most often cited by research in Biomaterials (152 citations), Molecular Medicine (31 citations) and Pharmaceutical Science (36 citations). O. I. Vernaya has collaborated with scholars based in Russia, Tajikistan and France. Frequent co-authors include Т. И. Шабатина, Mikhail Ya. Melnikov, В. П. Шабатин, А. М. Семенов, Vladimir I. Lozinsky, Andrew N. Fitch, M.G. Ezernitskaya, Владимир В. Чернышев, Yu. V. Maksimov and Т. Н. Ростовщикова. Their work appears in journals such as Molecules, International Journal of Biological Macromolecules and Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact